Concord Wealth Partners Jazz Pharmaceuticals PLC Transaction History

Concord Wealth Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$141.59 - $168.66 $11,185 - $13,324	-79 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$129.64 - $160.7 $907 - $1,124	7 Added 9.72%	79 $12,000
Q4 2021 Jan 21, 2022	BUY	$119.87 - $145.67 $7,791 - $9,468	65 Added 928.57%	72 $9,000
Q3 2021 Nov 09, 2021	SELL	$128.64 - $184.79 $7,461 - $10,717	-58 Reduced 89.23%	7 $1,000
Q2 2021 Jul 29, 2021	SELL	$160.2 - $186.42 $6,568 - $7,643	-41 Reduced 38.68%	65 $12,000
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $15,920 - $18,391	106 New	106 $17,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.